Evidence map›Paper›PMID 32505846›Full record

ArticleMedical hypotheses2020

The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?

Brenda D Jamerson, T Ho Haryadi

Open access · greenAbstract read
In one paragraph

Article in Medical hypotheses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Enhanced UV Direct Photolysis and UV/HWater, air, and soil pollution · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Brenda D JamersonDuke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC 27710. USA; Center on Health and Society, Duke University, Durham, NC, USA. Electronic address: bjamers@gmail.com.
T Ho HaryadiHillsborough, NC 27278, USA.
Duke University · USHillsborough Community College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults. Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen. As fever may have benefit in shortening the duration of viral illness, it is plausible to hypothesize that the antipyretic efficacy of ibuprofen may be hindering the benefits of a fever response when taken during the early stages of COVID-19 illness.

Indexed as

COVID-19 Drug TreatmentAcetaminophenAntipyreticsFeverHumansIbuprofenModels, TheoreticalPatient SafetyTreatment OutcomeAcetaminophenAntipyreticsIbuprofen

Identifiers

PMID32505846
PMCPMC7247463
OpenAlexW3031678220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.